APP and Alzheimer disease: Mir101 is known as a key post-transcriptional regulatory element that corresponds to the 3′-untranslated region (3′-UTR) of App mRNA, and its overexpression alleviates Aβ production and prevents progression of AD (Lin et al., 2019).